Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 172, Issue 12, 2005, Pages 1510-1516

  Stevenson, Nicola J ^b   Walker, Paul P ^b   Costello, Richard W ^b   Calverley, Peter M A ^a  

^a UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^b NONE

Author keywords

Breathlessness; Inspiratory reserve volume; Lung function; Lung hyperinflation

Indexed keywords

BRONCHODILATING AGENT;

ADULT; AGED; AIRFLOW; ARTICLE; BREATHING PATTERN; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DYSPNEA; EXPIRATORY FLOW; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; INSPIRATORY CAPACITY; LUNG MECHANICS; LUNG RESISTANCE; LUNG VOLUME; MALE; NEBULIZATION; PRIORITY JOURNAL; SPIROMETRY;

AGED; AGED, 80 AND OVER; AIRWAY RESISTANCE; BRONCHODILATOR AGENTS; DYSPNEA; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG VOLUME MEASUREMENTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY MECHANICS; SPIROMETRY; TREATMENT OUTCOME;

EID: 30444452071     PISSN: 1073449X     EISSN: 1073449X     Source Type: Journal    
DOI: 10.1164/rccm.200504-595OC     Document Type: Article

References (40)

1. Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J Suppl 2003;41:46s-53s.
2. Cydulka RK, McFadden ER Jr, Emerman CL, Sivinski LD, Pisanelli W, Rimm AA. Patterns of hospitalization in elderly patients with asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997;156:1807-1812.
3. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1418-1422.
4. Spencer S, Calverley PM, Burge PS, Jones PW. Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J 2004;23:698-702.
5. 1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the Lung Health Study. Am J Respir Crit Care Med 2001;164:358-364.
6. Donaldson GC, Seemungal TA, BhowmikA,Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002;57:847-852.
7. Seemungal TR, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, Maccallum P, Meade TW, Jeffries DJ, Johnston SL, et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:1618-1623.
8. Patel IS, Seemungal TA, Wilks M, Lloyd-Owen SJ, Donaldson GC, Wedzicha JA. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 2002;57:759-764.
9. Rennard S, Decramer M, Calverley PM, Pride NB, Soriano JB, Vermeire PA, Vestbo J. Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J 2002;20:799-805.
10. van der Molen T, Willemse BW, Schokker S, Ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003;1:13.
11. Rossi A, Gottfried SB, Zocchi L, Higgs BD, Lennox S, Calverley PM, Begin P, Grassino A, Milic-Emili J. Measurement of static compliance of the total respiratory system in patients with acute respiratory failure during mechanical ventilation: the effect of intrinsic positive endexpiratory pressure. Am Rev Respir Dis 1985;131:672-677.
12. Vitacca M, Porta R, Bianch L, Clini E, Ambrosino N. Differences in spontaneous breathing pattern and mechanics in patients with severe COPD recovering from acute exacerbation. Eur Respir J 1999;13:365-370.
13. Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;161:1608-1613.
14. Eltayara L, Becklake MR, Volta CA, Milic-Emili J. Relationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;154:1726-1734.
15. O'Donnell DE, Bertley JC, Chau LK, Webb KA. Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. Am J Respir Crit Care Med 1997;155:109-115.
16. O'Donnell DE, Lam M, Webb KA. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:542-549.
17. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004;364:709-721.
18. Stevenson NJ, Costello R, Calverley PMA. Symptomatic improvement during recovery from exacerbation of COPD [abstract]. Thorax 2001;56:S73.
19. Stevenson NJ, Costello R, Calverley PMA. Bronchodilator responses during acute exacerbations of COPD [abstract]. Am J Respir Crit Care Med 2001;163:A279.
20. Stevenson NJ, Donoghue S, Calverley PMA. Expiratory flow limitation in COPD patients during and after an acute exacerbation [abstract]. Am J Respir Crit Care Med 2001;163:A83.
21. Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000;117:398S-401S.
22. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-946.
23. American Thoracic Society. ATS standardization of spirometry: 1994 update. Am J Respir Crit Care Med 1994;152:1107-1136.
24. Calverley PM, Burge PS, Spencer S, Anderson JA, Jones PW. Bronchodilator reversibility testing in chronic obstructive pulmonary disease. Thorax 2003;58:659-664.
25. 2 muscarinic receptors in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:1320-1325.
26. Hadcroft J, Calverley PM. Alternative methods for assessing bronchodilator reversibility in chronic obstructive pulmonary disease. Thorax 2001;56:713-720.
27. Stevenson NJ, Calverley PM. Effect of oxygen on recovery from maximal exercise in patients with chronic obstructive pulmonary disease. Thorax 2004;59:668-672.
28. 2 in stable patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1990;141:1194-1197.
29. Jeffrey AA, Warren PM, Flenley DC. Acute hypercapnic respiratory failure in patients with chronic obstructive lung disease: risk factors and use of guidelines for management. Thorax 1992;47:34-40.
30. Costello R, Deegan P, Fitzpatrick M, McNicholas WT. Reversible hypercapnia in chronic obstructive pulmonary disease: a distinct pattern of respiratory failure with a favorable prognosis. Am J Med 1997;102:239-244.
31. Duffy N, Walker P, Diamantea F, Calverley P, Davies L. Intravenous aminophylline in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomized controlled trial. Thorax 2005;60:713-717.
32. O'Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;164:770-777.
33. Farre R, Peslin R, Rotger M, Barbera JA, Navajas D. Forced oscillation total respiratory resistance and spontaneous breathing lung resistance in COPD patients. Eur Respir J 1999;14:172-178.
34. Calverley PM, Koulouris NG. Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiology. Eur Respir J 2005;25:186-199.
35. Davies L, Angus RM, Calverley PMA. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet 1999;354:456-460.
36. Vathenen AS, Britton JR, Ebden P, Cookson JB, Wharrad HJ, Tattersfield AE. High-dose inhaled albuterol in severe chronic airflow limitation. Am Rev Respir Dis 1998;138:850-855.
37. Hay JG, Stone P, Carter J, Church S, Eyre-Brook A, Pearson MG, Woodcock AA, Calverley PM. Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease. Eur Respir J 1992;5:659-664.
38. O'Donnell DE, Lam M, Webb KA. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:1557-1565.
39. Killian KJ, Leblanc P, Martin DH, Summers E, Jones NL, Campbell EJM. Exercise capacity and ventilators, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis 1992;146:935-940.
40. Aliverti A, Stevenson N, Dellaca RL, Lo Mauro A, Pedotti A, Calverley PM.Regional chest wall volumes during exercise in chronic obstructive pulmonary disease. Thorax 2004;59:210-216.